Close Menu

droplet digital PCR

Digital PCR has the potential to supplant quantitative real-time PCR as the assay technology of choice for certain applications, particularly the detection and absolute quantification of low-level DNA targets in oncology and HIV research, industry stakeholders and early users sai

Droplet digital PCR is no better than real-time PCR at detecting and quantifying low levels of cell-associated HIV-1 genetic material from samples taken from patients both on and off antiviral therapy, according to newly published study.

QuantaLife also disclosed the identity of one of its beta-test partners, a laboratory at the Fred Hutchinson Cancer Research Center in Seattle that is using the platform for rare mutation detection.

Paladin Capital Group and other existing investors participated, as well as new investors Vital Financial and Mérieux Développement, the healthcare investment company of Institut Mérieux, which counts among its subsidiaries diagnostic firm BioMérieux.

Pages

Nature News examines how science in the UK may fare as Boris Johnson, the next prime minister, pursues Brexit.

CNN reports that Immigration and Customs Enforcement in the US has expanded its DNA testing to seven sites along the southern border.

In PNAS this week: role for exosomes in neuronal circuit development, tuberculosis pathogen enzymes, and more.

Undoing Obamacare protections could affect people's willingness to undergo genetic testing, Sarah Lawrence College's Laura Hercher and the University of Iowa College of Law's Anya Prince write at BuzzFeed News.